Evidence map›Paper›PMID 38534924›Full record

ArticleCurrent oncology (Toronto, Ont.)2024

Modeling 5-FU-Induced Chemotherapy Selection of a Drug-Resistant Cancer Stem Cell Subpopulation.

Amra Ramović Hamzagić, Danijela Cvetković, Marina Gazdić Janković, Nevena Milivojević Dimitrijević, Dalibor Nikolić, Marko Živanović, Nikolina Kastratović, Ivica Petrović, Sandra Nikolić, Milena Jovanović and 3 more

Open access · goldAbstract read
In one paragraph

Article in Current oncology (Toronto, Ont.), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Research progress on ferroptosis in drug resistance and therapy of gastric cancer.Journal of cancer research and clinical oncology · 2025
    Review
  2. Article
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Amra Ramović HamzagićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.
Danijela CvetkovićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0001-7767-1345
Marina Gazdić JankovićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0001-8151-9004
Nevena Milivojević DimitrijevićInstitute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.ORCID 0000-0002-4518-1066
Dalibor NikolićInstitute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.ORCID 0000-0001-5491-4586
Marko ŽivanovićInstitute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.ORCID 0000-0002-8833-8035
Nikolina KastratovićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-7238-7414
Ivica PetrovićFaculty of Medical Sciences, Department of Pathophysiology, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0003-2056-1158
Sandra NikolićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.
Milena JovanovićFaculty of Sciences, University of Kragujevac, Radoja Domanovića 12, 34000 Kragujevac, Serbia.ORCID 0000-0002-2003-8124
Dragana ŠeklićInstitute for Information Technologies Kragujevac, University of Kragujevac, Liceja Kneževine Srbije 1A, 34000 Kragujevac, Serbia.ORCID 0000-0002-2093-5335
Nenad FilipovićBioengineering Research and Development Center (BioIRC), Prvoslava Stojanovica 6, 34000 Kragujevac, Serbia.ORCID 0000-0001-9964-5615
Biljana LjujićFaculty of Medical Sciences, Department of Genetics, University of Kragujevac, 34000 Kragujevac, Serbia.ORCID 0000-0002-6759-2720
University of Kragujevac · RS

Funding

European Union's Horizon 2020 research and innovation programme No 952603 (SGABU)Junior projects of Faculty of Medical Sciences, University of Kragujevac JP 05/20Junior projects of Faculty of Medical Sciences, University of Kragujevac JP 06/20Junior projects of Faculty of Medical Sciences, University of Kragujevac JP 25/19Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-47/2023-01/200107Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-47/2023-01/200378Ministry of Science, Technological Development and Innovation of the Republic of Serbia 451-03-9/2021-14/200378Ministry of Science, Technological Development and Innovation of the Republic of Serbia JP 24/20
6 · The paper itself

Abstract

(1) Background: Cancer stem cells (CSCs) are a subpopulation of cells in a tumor that can self-regenerate and produce different types of cells with the ability to initiate tumor growth and dissemination. Chemotherapy resistance, caused by numerous mechanisms by which tumor tissue manages to overcome the effects of drugs, remains the main problem in cancer treatment. The identification of markers on the cell surface specific to CSCs is important for understanding this phenomenon. (2) Methods: The expression of markers CD24, CD44, ALDH1, and ABCG2 was analyzed on the surface of CSCs in two cancer cell lines, MDA-MB-231 and HCT-116, after treatment with 5-fluorouracil (5-FU) using flow cytometry analysis. A machine learning model (ML)-genetic algorithm (GA) was used for the in silico simulation of drug resistance. (3) Results: As evaluated through the use of flow cytometry, the percentage of CD24-CD44+ MDA-MB-231 and CD44, ALDH1 and ABCG2 HCT-116 in a group treated with 5-FU was significantly increased compared to untreated cells. The CSC population was enriched after treatment with chemotherapy, suggesting that these cells have enhanced drug resistance mechanisms. (4) Conclusions: Each individual GA prediction model achieved high accuracy in estimating the expression rate of CSC markers on cancer cells treated with 5-FU. Artificial intelligence can be used as a powerful tool for predicting drug resistance.

Indexed as

Artificial IntelligenceNeoplasmsAldehyde Dehydrogenase 1 FamilyCell Line, TumorFluorouracilHumansNeoplastic Stem CellsAldehyde Dehydrogenase 1 FamilyFluorouracilcancer stem cellschemotherapy resistancemachine learning model

Identifiers

PMID38534924
PMCPMC10968802
OpenAlexW4392166984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.